TFS Capital’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
2017
Q2
$231K Sell
2017
Q1
$314K Buy
2016
Q4
Sell
2016
Q3
$32K Buy
2016
Q2
Sell
2016
Q1
$17K Sell
2015
Q4
$74K Sell
2015
Q3
$228K Sell
2015
Q2
$552K Sell
2015
Q1
$818K Buy
2014
Q4
$161K Sell
2014
Q3
$595K Buy
2014
Q2
$762K Sell
2014
Q1
$1.08M Buy
2013
Q4
$351K Buy
2013
Q3
$151K Sell
2013
Q2
$413K Buy